H. Cheng

发表

Pharmacokinetics and bioavailability of montelukast sodium (MK‐0476) in healthy young and elderly volunteers

M. Merz, M. Seiberling, Jamie J. Zhao, 1997, Biopharmaceutics & drug disposition.

Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers.

D. Margolskee, D. Schoors, P. Larson, 1995, British journal of clinical pharmacology.

Assessment of the antidepressant activity of dothiepin and its metabolites by preclinical tests.

Trevor R. Norman, G. Burrows, A. Fulton, 1982, Journal of affective disorders.

The bioavailability and nonlinear pharmacokinetics of MK‐679 in humans

J. Seibold, J. Schwartz, D. Ebel, 1994, Biopharmaceutics & drug disposition.

Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.

B. Matuszewski, C. Chavez-Eng, S. Varga, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Mean residence time of drugs administered non‐instantaneously and undergoing linear tissue distribution and reversible metabolism and linear or non‐linear elimination from the central compartment

Haiyung Cheng, H. Cheng, 1995, Biopharmaceutics & drug disposition.

Determination of bioavailability and systemically available fractions of drugs undergoing reversible metabolism: application to 4-amino-5-chloro-2-[2-(methylsulfinyl)ethoxy]-N-[2- (diethylamino)ethyl]benzamide and its sulfide and sulfone metabolites in rats.

K. Hwang, B. Kuo, J. C. Poole, 1994, Journal of pharmaceutical sciences.

A method for calculating the mean transit times and distribution rate parameters of interconversion metabolites

Haiyung Cheng, H. Cheng, 1993, Biopharmaceutics & drug disposition.

Noncompartmental determination of the mean residence time and steady-state volume of distribution during multiple dosing.

W. Jusko, H. Cheng, 1991, Journal of pharmaceutical sciences.

Drug redistribution and mean transit time concepts for nonlinear pharmacokinetic systems

W. Jusko, H. Cheng, 1991, Biopharmaceutics & drug disposition.

Relationships between steady-state and single-dose plasma drug concentrations for pharmacokinetic systems with nonlinear elimination.

W. Jusko, H. Cheng, 1989, Biopharmaceutics & drug disposition.

Identification of urinary metabolites of 8-methyl-8-azabicyclo-[3,2,1] octan-3-yl 3,5-dichlorobenzoate (MDL 72,222) in the dog and monkey.

W. P. Gordon, H. Cheng, N. Landmesser, 1992, Drug metabolism and disposition: the biological fate of chemicals.

Pharmacokinetics and metabolic interconversion of intravenous 4-amino-5-chloro-2-[(methylsulfinyl)ethoxy]-N-[2-(diethylamino)ethyl] benzamide and its sulfide and sulfone metabolites in rats.

K. Hwang, B. Kuo, J. C. Poole, 1993, Journal of pharmaceutical sciences.

Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.

R. Wang, L. Liu, H. Cheng, 1996, Drug metabolism and disposition: the biological fate of chemicals.

Metabolic disposition of simvastatin in patients with T-tube drainage.

S. Pond, J. Gilbert, J. Rogers, 1994, Drug metabolism and disposition: the biological fate of chemicals.

Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist.

T. Olah, W. Polvino, B. Gertz, 1997, British journal of clinical pharmacology.

Post‐transplant hyperlipidaemia: low‐dose lovastatin lowers atherogenic lipids with without plasma accumulation of lovastatin

K. Berg, L. Gullestad, S. Simonsen, 1997, Journal of internal medicine.

Regarding dose-independent pharmacokinetic parameters in nonlinear pharmacokinetics.

W J Jusko, P Veng-Pedersen, H Y Cheng, 1991, Journal of pharmaceutical sciences.

A method for calculating the mean transit times and distribution rate parameters of metabolites without separate intravenous administration of metabolite.

H. Cheng, 1992, Journal of pharmaceutical sciences.

A multidimensional deconvolution method for evaluating the absorption of drugs undergoing reversible metabolism and presystemic metabolite formation.

W. Gillespie, H. Cheng, 1993, Journal of pharmaceutical sciences.